Highlights From the 2026 Duke fAVS Course

Retina fellows gathered to learn from the experts and gain hands-on wet lab experience.

Emily H. Jung, MD; Naveen Karthik, MD; Haley S. D’Souza, MD, MS; Omar A. Halawa, MD; and Ryan Sameen Meshkin, MD

IRD Clinical Trial Endpoints: Lessons Learned

Choosing the right outcome measures for inherited retinal disease trials requires matching endpoints to disease biology, therapeutic mechanism, and patient experience.

Melissa Yuan, MD, and Ahmad Al Moujahed, MD, PhD

Keep Up With the IRD Patient Standard of Care

Christine Kay, MD; Vinit B. Mahajan, MD, PhD; and Jose S. Pulido, MD, MS, MBA, MPH

Rare Disease Mystery Cases

Can you diagnose these unusual cases based on the examination and imaging?

Kenneth C. Fan, MD, MBA; Caroline C. Awh, MD; Nimesh A. Patel, MD; Marta Stevanovic, MD, MSc; Maria Emfietzoglou, MD; Demetrios Vavvas, MD, PhD; Mary V. Lang; Lisa A. Schimmenti, MD; Brittni A. Scruggs, MD, PhD; Yicheng Bao, MD; and Hossein Ameri, MD, PhD, FRCSI, MRCOphth